Your browser doesn't support javascript.
loading
Value of incorporating newly identified risk factors into risk prediction for chemotherapy-induced febrile neutropenia.
Li, Yanli; Family, Leila; Chen, Lie H; Page, John H; Klippel, Zandra; Xu, Lanfang; Chao, Chun R.
Affiliation
  • Li Y; Center for Observational Research, Amgen Inc., South San Francisco, CA, USA.
  • Family L; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.
  • Chen LH; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.
  • Page JH; Center for Observational Research, Amgen Inc., Thousand Oaks, CA, USA.
  • Klippel Z; Clinical Development, Amgen Inc., Thousand Oaks, CA, USA.
  • Xu L; Medhealth Statistical Consulting Inc., Solon, OH, USA.
  • Chao CR; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.
Cancer Med ; 7(8): 4121-4131, 2018 08.
Article in En | MEDLINE | ID: mdl-29953736

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chemotherapy-Induced Febrile Neutropenia Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Cancer Med Year: 2018 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chemotherapy-Induced Febrile Neutropenia Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Cancer Med Year: 2018 Document type: Article Affiliation country: United States Country of publication: United States